Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11.2 mg ZGN-440 for injectable suspension----1件: 193 💬
21.8 mg ZGN-440 for injectable suspension----1件: 193 💬
3[AZP-531]----1件: 193 💬
4[H01BB02]----1件: 193 💬
5[RGH-706]----1件: 193 💬
6Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --25件: 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
7ACOMPLIA 20 mg film-coated tablets----1件: 193 💬
8Acylated and unacylated ghrelin dosages----3件: 193, 201, 202 💬
9ANASTROZOLE1件: Anastrozole1件: Anastrozole 💬 1件: CYP19A1 💬 2件: Ovarian steroidogenesis, Steroid hormone biosynthesis 💬3件: 78, 86, 193 💬
10ARD-101----1件: 193 💬
11AZP-531----1件: 193 💬
12B. lactis B94----1件: 193 💬
13Behavioral: Eating----1件: 193 💬
14Beloranib1件: Beloranib---1件: 193 💬
15Biopsy----7件: 28, 34, 51, 65, 97, 193, 285 💬
16Blood draw----16件: 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
17BMB-101----3件: 140, 144, 193 💬
18Byetta----2件: 78, 193 💬
19Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬20件: 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
20Cannabidiol Oral Solution1件: Cannabidiol1件: Cannabidiol 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 140, 144, 145, 193 💬
21Carbetocin1件: Carbetocin1件: Carbetocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
22CBDV Compound----1件: 193 💬
23Choline1件: Choline1件: Choline 💬 --4件: 93, 171, 193, 299 💬
24Coenzyme Q10----11件: 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
25CSTI-500----1件: 193 💬
26D.3.2 Product code where applicable13:----1件: 193 💬
27DCCR----1件: 193 💬
28DCCR (Diazoxide Choline) Extended- Release Tablet2件: Choline,
Diazoxide		3件: Diazoxide ,
Choline ,
Diazoxide choline 💬 		2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
29DEXA, blood tests, H.G.P.O, osseous age.----1件: 193 💬
30Diazoxide1件: Diazoxide2件: Diazoxide ,
Diazoxide choline 💬 		2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬2件: 13, 193 💬
31DIAZOXIDE CHOLINE2件: Choline,
Diazoxide		3件: Diazoxide ,
Choline ,
Diazoxide choline 💬 		2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
32Diazoxide choline controlled-release tablet2件: Choline,
Diazoxide		3件: Diazoxide ,
Choline ,
Diazoxide choline 💬 		2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193 💬
33EU/1/06/362/003: 5µg (1 pen)----1件: 193 💬
34Eutropin----1件: 193 💬
35EXENATIDE1件: Exenatide1件: Exenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 6, 17, 72, 78, 193, 233 💬
36FE 992097----1件: 193 💬
37Fluimucil----1件: 193 💬
38Fluimucil (acetylcysteine)1件: Acetylcysteine1件: Acetylcysteine 💬 --1件: 193 💬
39Follow-up study of the treated cohort----1件: 193 💬
40GENOTONORM----1件: 193 💬
41Genotonorm Miniquick 0,2 mg----1件: 193 💬
42Genotropin----6件: 13, 77, 107, 187, 193, 222 💬
43GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made.----1件: 193 💬
44Genotropin GoQuick----1件: 193 💬
45GH treatment (Somatropin)----1件: 193 💬
46GLWL-01----1件: 193 💬
47Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
48Growth Hormone----10件: 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
49Growth hormone (Genotonorm® or Omnitrope®)----1件: 193 💬
50Guanfacine1件: Guanfacine2件: Guanfacine hydrochloride ,
Guanfacine 💬 		1件: ADRA2A 💬 4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 193 💬
51Guanfacine Extended Release1件: Guanfacine2件: Guanfacine hydrochloride ,
Guanfacine 💬 		1件: ADRA2A 💬 4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 193 💬
52Guanfacine extended release (GXR)1件: Guanfacine2件: Guanfacine hydrochloride ,
Guanfacine 💬 		1件: ADRA2A 💬 4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 193 💬
53H01BB02----1件: 193 💬
54Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten----1件: 193 💬
55INN Not yet proposed----1件: 193 💬
56Intranasal oxytocin1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬2件: 127, 193 💬
57Intranasal Oxytocin (IN-OXT)1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
58Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 13, 75, 77, 193 💬
59Livoletide1件: Livoletide---1件: 193 💬
60Medical air1件: Medical air1件: Air, medical 💬 --3件: 85, 86, 193 💬
61Medical Air vs Oxygen2件: Medical air,
Oxygen		2件: Oxygen ,
Air, medical 💬 		--1件: 193 💬
62Metoprolol1件: Metoprolol4件: Metoprolol tartrate ,
Metoprolol succinate ,
Metoprolol ,
Metoprolol fumarate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226 💬
63Metoprolol succinate1件: Metoprolol4件: Metoprolol tartrate ,
Metoprolol succinate ,
Metoprolol ,
Metoprolol fumarate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 58, 113, 193 💬
64METOPROLOL SUCCINATE (PH. EUR.)1件: Metoprolol4件: Metoprolol tartrate ,
Metoprolol succinate ,
Metoprolol ,
Metoprolol fumarate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 193 💬
65Metoprololsuccinat Orion 25mg----1件: 193 💬
66Metoprololsuccinat ”Orion” 25mg----1件: 193 💬
67METYRAPONE1件: Metyrapone1件: Metyrapone 💬 1件: CYP11B1 💬 3件: Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬2件: 75, 193 💬
68Muscle biopsy----2件: 193, 344 💬
69NBT-NM108----1件: 193 💬
70NNZ-25911件: NNZ-2591---2件: 193, 201 💬
71Norditropin SimpleXx----5件: 3, 97, 107, 193, 195 💬
72Nutropin AQ----4件: 78, 134, 193, 299 💬
73Octreotide1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬8件: 67, 75, 77, 84, 85, 89, 193, 227 💬
74OMNITROPE----1件: 193 💬
75OSSITOCINA----2件: 127, 193 💬
76OT----1件: 193 💬
77Other: Blood Samples----13件: 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
78Other: Control----12件: 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
79Other: exercise and blood tests----1件: 193 💬
80Other: Follow-up study of the untreated cohort----1件: 193 💬
81Other: Low dose (1 mcg) ACTH stimulation test----1件: 193 💬
82Other: Overnight metyrapone test1件: Metyrapone1件: Metyrapone 💬 1件: CYP11B1 💬 3件: Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬1件: 193 💬
83Oxygen1件: Oxygen1件: Oxygen 💬 --30件: 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
84Oxytocin1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬8件: 6, 70, 72, 127, 168, 193, 206, 226 💬
85Oxytocin (OXT) continuous1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
86Oxytocin nasal spray1件: Oxytocin1件: Oxytocin 💬 1件: OXTR 💬 5件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬3件: 70, 72, 193 💬
87Part A: RM-718----1件: 193 💬
88Part B: RM-718----1件: 193 💬
89Part C: RM-718----1件: 193 💬
90Part D: RM-718----1件: 193 💬
91Physiological serum (Sodium chloride)1件: Sodium chloride1件: Sodium chloride 💬 --1件: 193 💬
92Pitolisant1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 6, 113, 193 💬
93Pitolisant oral tablets1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 193 💬
94Pitolisant tablet1件: Pitolisant2件: Pitolisant ,
Pitolisant hydrochloride 💬 		1件: HRH3 💬 2件: Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 193 💬
95Prebiotics with galactomannan and oligofructose----1件: 193 💬
96Probiotic----10件: 2, 6, 13, 93, 96, 97, 127, 193, 266, 299 💬
97Probiotics including B. lactis B420, B. lactis HN019, B. animalis Bb-12, L. rhamnosus GG----1件: 193 💬
98R05CB01----1件: 193 💬
99RAD011----1件: 193 💬
100RECOMBINANT HUMAN GROWTH HORMON----1件: 193 💬
101Recombinant human growth hormone----4件: 77, 193, 265, 276 💬
102Recombinant Human Growth Hormone (rhGH) Injection----1件: 193 💬
103Recombinant Somatropin----1件: 193 💬
104RGH-706----1件: 193 💬
105RGH-706 HYDROCHLORIDE----1件: 193 💬
106Rimonabant1件: Rimonabant1件: Rimonabant 💬 1件: CNR1 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193 💬
107RM-493----2件: 193, 202 💬
108Sandostatin LAR----5件: 67, 77, 84, 193, 227 💬
109Saxenda----1件: 193 💬
110Setmelanotide1件: Setmelanotide2件: Setmelanotide ,
Setmelanotide acetate 💬 		1件: MC4R 💬 3件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 134, 193, 202, 236, 265 💬
111Sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --31件: 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
112Somatropin----14件: 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
113Somatropin - adult cohort----1件: 193 💬
114Somatropin - GH naïve pediatric cohort----1件: 193 💬
115Somatropin - GH treated cohort----1件: 193 💬
116SOMATROPIN FOR INJECTION----1件: 193 💬
117Subcutaneous Beloranib in Suspension1件: Beloranib---1件: 193 💬
118Syntocinon----2件: 127, 193 💬
119Syntocinon nasal spray----1件: 193 💬
120Syntocinon®/- Spray----1件: 193 💬
121Tesofensine1件: Tesofensine---2件: 6, 193 💬
122TESOFENSINE CITRATE1件: Tesofensine---1件: 193 💬
123Tesofensine/Metoprolol2件: Metoprolol,
Tesofensine		4件: Metoprolol tartrate ,
Metoprolol succinate ,
Metoprolol ,
Metoprolol fumarate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 193 💬
124Tesomet----1件: 193 💬
125Tirzepatide1件: Tirzepatide1件: Tirzepatide 💬 2件: GIPR,
GLP1R 💬 		4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 67, 96, 97, 193, 233, 265 💬
126TOPIRAMATE1件: Topiramate1件: Topiramate 💬 37件: CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		55件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Cadherin signaling, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, IgSF CAM signaling, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 97, 140, 144, 156, 193 💬
127VYKAT XR----1件: 193 💬
128ZGN-440----1件: 193 💬
129ZGN-440 for Injectable Suspension----1件: 193 💬
130ZGN-440 sterile diluent----1件: 193 💬